Blue Water Life Science Advisors, LP Maxcyte, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $103 Million
- Q2 2024
A detailed history of Blue Water Life Science Advisors, LP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 603,937 shares of MXCT stock, worth $2.34 Million. This represents 2.3% of its overall portfolio holdings.
Number of Shares
603,937
Previous 603,937
-0.0%
Holding current value
$2.34 Million
Previous $2.53 Million
6.44%
% of portfolio
2.3%
Previous 2.38%
Shares
3 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
65MCall Options Held
600Put Options Held
2.7K-
Black Rock Inc. New York, NY8.14MShares$31.5 Million0.0% of portfolio
-
Cadian Capital Management, LP New York, NY7.62MShares$29.5 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.65MShares$21.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$20 Million0.01% of portfolio
-
Vitruvian Partners LLP5.04MShares$19.5 Million5.8% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $394M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...